Skip to content

Apotheek Schuttershof: what changed

BE 0878.869.290NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€132,604
2024 · €181,813-€49,208
Equity
€251,179
2024 · €247,575+€3,604
Cash
€76,756
2024 · €169,219-€92,463
Balance sheet total
€849,063
2024 · €886,682-€37,619

Largest movements

2024 to 2025
Assets
  • Cash -€92,463

    down €92,463 (-54.6%), from €169,219 to €76,756

    mainly Contributions, distributions and other (-€129,000) and Investment in fixed assets (net) (-€71,489)

  • Receivables within one year +€30,557

    up €30,557 (+25.9%), from €117,784 to €148,341

    of which Trade receivables: +€19,519

  • Tangible fixed assets +€12,855

    up €12,855 (+4.2%), from €302,917 to €315,772

    of which Other tangible fixed assets: +€20,514

  • Financial fixed assets +€9,051

    first reported in 2025, at €9,051

Equity and liabilities
  • Debts after one year -€22,300

    down €22,300 (-15.6%), from €143,092 to €120,792

  • Other debts -€18,308

    down €18,308 (-4.4%), from €417,869 to €399,560

  • Tax, wage and social debts -€10,238

    down €10,238 (-74.5%), from €13,733 to €3,495

    of which Remuneration and social security: -€10,612

  • Trade debts +€9,344

    up €9,344 (+23.4%), from €40,015 to €49,358

Income statement
  • Gross operating margin -€127,520

    down €127,520 (-35.8%), from €356,050 to €228,530

  • Staff costs -€80,813

    down €80,813 (-66.4%), from €121,731 to €40,918

  • Depreciation +€5,791

    up €5,791 (+13.2%), from €43,792 to €49,583

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €181,813
Gross operating margin -€127,520
Staff costs +€80,813
Depreciation -€5,791
Other operating charges +€541
Financial income -€1,312
Financial charges +€1,929
Taxes +€2,132
Result 2025 €132,604
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€130,326
Investment -€71,489
Financing -€151,300
Cash 2024 €169,219
Net result for the year +€132,604
Depreciation +€49,583
Stocks and contracts -€3,765
Receivables within one year -€30,557
Deferred charges and accrued income +€1,384
Trade debts +€9,344
Tax, wage and social debts -€10,238
Other debts -€18,308
Accrued charges and deferred income +€279
Investment in fixed assets (net) -€71,489
Debts after one year -€22,300
Contributions, distributions and other -€129,000
Cash 2025 €76,756
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €886,682 €849,063 -€37,619 -4.2%
Fixed assets 21/28 €302,917 €324,823 +€21,906 +7.2%
Tangible fixed assets 22/27 €302,917 €315,772 +€12,855 +4.2%
Land and buildings 22 €6,854 €6,344 -€510 -7.4%
Plant, machinery and equipment 23 €4,075 €2,199 -€1,876 -46.0%
Furniture and vehicles 24 €15,840 €10,567 -€5,273 -33.3%
Other tangible fixed assets 26 €276,147 €296,661 +€20,514 +7.4%
Financial fixed assets 28 - €9,051 +€9,051
Current assets 29/58 €583,765 €524,240 -€59,525 -10.2%
Stocks and contracts in progress 3 €294,771 €298,537 +€3,765 +1.3%
Stocks 30/36 €294,771 €298,537 +€3,765 +1.3%
Amounts receivable within one year 40/41 €117,784 €148,341 +€30,557 +25.9%
Trade receivables 40 €95,045 €114,565 +€19,519 +20.5%
Other amounts receivable 41 €22,739 €33,776 +€11,037 +48.5%
Cash at bank and in hand 54/58 €169,219 €76,756 -€92,463 -54.6%
Deferred charges and accrued income 490/1 €1,991 €607 -€1,384 -69.5%
Total equity and liabilities 10/49 €886,682 €849,063 -€37,619 -4.2%
Equity 10/15 €247,575 €251,179 +€3,604 +1.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €228,975 €232,579 +€3,604 +1.6%
Tax-exempt reserves 132 €337 €337 = 0.0%
Distributable reserves 133 €228,638 €232,242 +€3,604 +1.6%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €639,107 €597,884 -€41,223 -6.5%
Amounts payable after more than one year 17 €143,092 €120,792 -€22,300 -15.6%
Financial debts 170/4 €143,092 €120,792 -€22,300 -15.6%
Amounts payable within one year 42/48 €495,774 €476,572 -€19,202 -3.9%
Current portion of amounts payable after more than one year 42 €24,158 €24,158 = 0.0%
Trade debts 44 €40,015 €49,358 +€9,344 +23.4%
Suppliers 440/4 €40,015 €49,358 +€9,344 +23.4%
Taxes, remuneration and social security 45 €13,733 €3,495 -€10,238 -74.5%
Taxes 450/3 €462 €836 +€374 +80.9%
Remuneration and social security 454/9 €13,271 €2,659 -€10,612 -80.0%
Other amounts payable 47/48 €417,869 €399,560 -€18,308 -4.4%
Accrued charges and deferred income 492/3 €241 €520 +€279 +116%
Remuneration, social security and pensions 62 €121,731 €40,918 -€80,813 -66.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €43,792 €49,583 +€5,791 +13.2%
Other operating charges 640/8 €1,062 €521 -€541 -50.9%
Gross operating margin 9900 €356,050 €228,530 -€127,520 -35.8%
Operating profit (loss) 9901 €189,464 €137,507 -€51,957 -27.4%
Financial income 75/76B €3,399 €2,087 -€1,312 -38.6%
Recurring financial income 75 €3,399 €2,087 -€1,312 -38.6%
Financial charges 65/66B €8,444 €6,515 -€1,929 -22.8%
Recurring financial charges 65 €8,444 €6,515 -€1,929 -22.8%
Profit (loss) for the period before taxes 9903 €184,420 €133,080 -€51,340 -27.8%
Income taxes 67/77 €2,607 €475 -€2,132 -81.8%
Profit (loss) for the period 9904 €181,813 €132,604 -€49,208 -27.1%
Profit (loss) for the period to be appropriated 9905 €181,813 €132,604 -€49,208 -27.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€695,136 to €922,955

Midpoint €790,061 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €251,179
Capitalised earnings €1.1m to €1.6m
Indication €695,136 to €922,955

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€251,179
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€251,179

Capitalised earnings

net result for the year (9904)
2025
€132,604
2024
€181,813
2023
€164,001
2022
€203,459
2021
€195,825
Average result
€159,473
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.1m / €1.3m / €1.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.